Article
Found 2 results
Filters: Keyword is Non-small cell lung cancer [Clear All Filters]
. A combination of vinorelbine and oxaliplatin to restrain the progression of non-small cell lung cancer via inhibition of the PI3K/AKT/ABCG2 axis. Pharmacognosy Magazine [Internet]. 2022;18(80):859-870. http://www.phcog.com/text.asp?2022/18/80/859/361762
PDF (10.99 MB)
. Naringenin sensitizes lung cancer NCI-H23 cells to radiation by downregulation of akt expression and metastasis while promoting apoptosis. Pharmacognosy Magazine. 2020;16(70):229-235.
PDF (1.56 MB)